Fund VI

---

Size: EUR 1,900 million

Year: 2006

Investment focus/criteria:

Geographic scope:Primarily Nordic Region, selected investments in Europe
Industries:Diversified, special focus on and expertise in healthcare investments
Main focus:Large and medium-sized companies
Key Characteristics:Opportunities for structural transformation, operational improvements, buy & build, emerging market growth, strategic repositioning, international expansion and growth acceleration

---

Investors:

Investors in Nordic Capital Funds are 60 institutions, e.g. pension funds, banks and insurance companies 

The Nordic region represents 20% of committed capital, Europe 30%,
the US 40% and rest of the world 10%

Investments:

Investment year	Company	Industry	Turnover (EUR m)*	Exit
2005	Luvata >	Fabricated copper products	709
2005	Nycomed	Pharmaceuticals		2011
2006	Fougera Pharmaceuticals Inc. (formerly Nycomed US Inc.) >	Specialty pharmaceuticals	333
2006	Brightpoint	Mobile phone distributor		2007
2006	Menigo >	Food service	497
2006	Capio >	Provider of health care services	1470
2007	Unilabs >	Laboratory and radiology services	427
2007	Thule >	Leisure, outdoor industry	597
2007	Nefab >	Packaging solutions	312
2008	CPS Color >	Colour tinting systems	181
2008	ConvaTec >	Wound care and therapeutic products	1140

* 2010 sales for companies still in portfolio; sales at exit for divested companies

---

Contact information:

Nordic Capital Limited
26 Esplanade, St Helier Jersey JE2 3QA
Tel: +44 1534 605 100
Fax: +44 1534 605 199
For all investor communications: investor@nordiccapital.je